Study S000919

Trial of Innovative Fat-loss Focused Approaches in Patients With Class I Obesity: a Comparative Study

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07866183
Acronym: TIFFANY
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: NONE
Status: RECRUITING
Enrollment: 120
Start: 2026-06-29
Primary completion: 2027-06
Lead sponsor: National Medical Research Center for Therapy and Preventive Medicine
Conditions: Class I Obesity
Interventions: DRUG:Tirzepatide; DEVICE:Transcutaneous auricular vagus nerve stimulation
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Percentage reduction in body weight [Baseline, Week 8, Week 16, and Week 24.]
Percentage reduction in waist-to-height ratio [Baseline, Week 8, Week 16, and Week 24]
Percentage reduction in epicardial adipose tissue thickness [Baseline and Week 24.]
Percentage reduction in visceral adipose tissue [Baseline and Week 24]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.